ALS Biopharma receives ADDF grant to build up therapeutics against Alzheimer’s disease The Alzheimer’s Medication Discovery Basis announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics directed at clearing toxic proteins implicated in Alzheimer’s disease.This program will identify and develop small-molecule brain-penetrant inducers of heat shock protein 70 order generic levitra . Allen Reitz, CEO of ALS Biopharma. ‘We are excited to support ALS Biopharma’s innovative plan in this target region,’ stated Howard Fillit, MD, Executive Director of the ADDF.’..
Soffa, MD, MPA, FACR, AIM’s senior vice president, Medical Affairs.. Purpose releases new educational podcasts on its patient safety website section American Imaging Administration, Inc. , a leading diagnostic imaging benefit administration and technology organization with health plan clients representing more than 35 million customers and an working subsidiary of WellPoint, Inc. Thomas Power, MD, FACC, MRCPI, AIM’s medical director for Cardiology, the most recent set of podcasts discuss radiation publicity associated with cardiac imaging procedures including Cardiac Computerized Tomography . Power.’ Related StoriesNon-invasive diagnostic imaging can rule out CAD in about 50 percent of ladies with atypical upper body painResearchers report new breakthrough in countering deadly effects of radiation exposureStudy looks at influence of amyloid imaging on diagnosis, management of individuals with cognitive impairmentPodcasts will be the latest element of AIM’s Patient Protection Program.